KYMERA THERAPEUTICS INC's ticker is KYMR and the CUSIP is 501575104. A total of 129 filers reported holding KYMERA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.11 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,401,064 | -43.9% | 100,796 | -7.2% | 0.00% | -50.0% |
| Q2 2023 | $2,495,978 | -58.9% | 108,568 | -47.0% | 0.00% | -50.0% |
| Q1 2023 | $6,066,180 | +84.0% | 204,731 | +55.0% | 0.00% | +33.3% |
| Q4 2022 | $3,296,817 | -24.7% | 132,084 | -34.3% | 0.00% | 0.0% |
| Q3 2022 | $4,376,000 | +16.5% | 201,040 | +5.4% | 0.00% | 0.0% |
| Q2 2022 | $3,757,000 | +307.0% | 190,801 | +775.3% | 0.00% | +200.0% |
| Q1 2022 | $923,000 | -82.2% | 21,799 | -73.3% | 0.00% | -66.7% |
| Q4 2021 | $5,184,000 | +65.5% | 81,651 | +53.1% | 0.00% | +50.0% |
| Q3 2021 | $3,133,000 | -22.6% | 53,338 | -36.1% | 0.00% | 0.0% |
| Q2 2021 | $4,048,000 | +63.6% | 83,465 | +31.1% | 0.00% | 0.0% |
| Q1 2021 | $2,475,000 | +1864.3% | 63,685 | +3034.1% | 0.00% | – |
| Q4 2020 | $126,000 | – | 2,032 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Deer IX & Co. Ltd. | 1,755,356 | $97,949,000 | 48.97% |
| Trustees of Columbia University in the City of New York | 463,298 | $28,724,000 | 38.38% |
| AJU IB Investment Co., Ltd. | 704,059 | $43,652,000 | 16.52% |
| BVF INC/IL | 2,630,658 | $163,101,000 | 6.42% |
| Redmile Group, LLC | 2,720,489 | $168,670,000 | 2.04% |
| Bain Capital Life Sciences Investors, LLC | 479,605 | $29,735,000 | 1.87% |
| Rock Springs Capital Management LP | 713,865 | $44,260,000 | 0.94% |
| SPHERA FUNDS MANAGEMENT LTD. | 147,700 | $9,157,000 | 0.81% |
| HighVista Strategies LLC | 17,117 | $1,061,000 | 0.68% |
| Logos Global Management LP | 110,920 | $6,877,000 | 0.59% |